Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zahid Bonday

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Biology : CB|June 9, 2004
Dynamics of centromere and kinetochore proteins; implications for checkpoint signaling and silencingJagesh V Shah, Elliot Botvinick, Zahid Bonday, et al.
Journal of Computer-Aided Molecular Design|June 25, 2008
Structure-based design of Aurora A & B inhibitorsAnders Poulsen, Anthony William, Angeline Lee, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2012
Thieno[3,2-d]pyrimidin-4(3H)-one derivatives as PDK1 inhibitors discovered by fragment-based screeningAngeline C-H Lee, Pondy Murugappan Ramanujulu, Anders Poulsen, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2010
Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activityHaishan Wang, Ze-Yi Lim, Yan Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2010
Synthesis and evaluation of alkenyl indazoles as selective Aurora kinase inhibitorsStéphanie Blanchard, Anthony D William, Angeline C-H Lee, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2012
2-anilino-4-aryl-8H-purine derivatives as inhibitors of PDK1Stéphanie Blanchard, Chang Kai Soh, Chai Ping Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2012
Crystal structure of the human PRMT5:MEP50 complexStephen Antonysamy, Zahid Bonday, Robert M Campbell, et al.
Molecular Cancer Therapeutics|March 4, 2010
SB939, a novel potent and orally active histone deacetylase inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancerVeronica Novotny-Diermayr, Kanda Sangthongpitag, Chang Yong Hu, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2009
N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activityHaishan Wang, Niefang Yu, Hongyan Song, et al.
The Journal of Clinical Investigation|November 24, 2015
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growthMichael Dewaele, Tommaso Tabaglio, Karen Willekens, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Biology : CB|June 9, 2004
Dynamics of centromere and kinetochore proteins; implications for checkpoint signaling and silencingJagesh V Shah, Elliot Botvinick, Zahid Bonday, et al.
Journal of Computer-Aided Molecular Design|June 25, 2008
Structure-based design of Aurora A & B inhibitorsAnders Poulsen, Anthony William, Angeline Lee, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2012
Thieno[3,2-d]pyrimidin-4(3H)-one derivatives as PDK1 inhibitors discovered by fragment-based screeningAngeline C-H Lee, Pondy Murugappan Ramanujulu, Anders Poulsen, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2010
Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activityHaishan Wang, Ze-Yi Lim, Yan Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2010
Synthesis and evaluation of alkenyl indazoles as selective Aurora kinase inhibitorsStéphanie Blanchard, Anthony D William, Angeline C-H Lee, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2012
2-anilino-4-aryl-8H-purine derivatives as inhibitors of PDK1Stéphanie Blanchard, Chang Kai Soh, Chai Ping Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2012
Crystal structure of the human PRMT5:MEP50 complexStephen Antonysamy, Zahid Bonday, Robert M Campbell, et al.
Molecular Cancer Therapeutics|March 4, 2010
SB939, a novel potent and orally active histone deacetylase inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancerVeronica Novotny-Diermayr, Kanda Sangthongpitag, Chang Yong Hu, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2009
N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activityHaishan Wang, Niefang Yu, Hongyan Song, et al.
The Journal of Clinical Investigation|November 24, 2015
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growthMichael Dewaele, Tommaso Tabaglio, Karen Willekens, et al.
Pageof 2